
Trials show immune drugs effective in advanced melanomas
Results of two clinical trials reported at the American Society for Clinical Oncology (ASCO) Annual Meeting 2015 show continued promise of immune therapies nivolumab and pembrolizumab against advanced melanomas, specifically ...
Jun 1, 2015
0
8